RE:Competition.Hey Dave,
TST's investor presentation (Feb-19 version) lists 10 competitors on page 21. The title of the slide is "MCNA - No Late Stage Competiton." It includes the FDA identifier for each clinical trial so you can go to the FDA website and read about the most current status for yourself. Heat Biologics is shown in the list, but their therapy is called HS-401 according to the presentation, not the HS-410 you quoted. I don't see the other competitor you mention.
Do your fellow investors a favour and send an e-mail to Don Olds to warn him he missed a key competitor. And then take 30 minutes and read the entire presentation again. It appears you missed a lot on your first reading.